1

Alfresa Holdings

Alfresa Holdings
Leadership team

Mr. Ryuji Arakawa (Pres & Representative Director)

Toshiki Tanaka (VP, Exec. Officer of Gen Affairs, HR Planning, Digital Transformation (DX) and Compliance & Dir)

Mr. Seiichi Kishida (Deputy Pres, Assistant to the Pres for Fin Planning and Corp. Communication & Director)

Products/ Services
Biotechnology, Health Care, Manufacturing
Number of Employees
1,000 - 20,000
Headquarters
Tokyo, Tokyo, Japan
Established
2003
Company Registration
SEC CIK number: 0000002784
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
TYO:2784
Overview
Location
Summary

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

History

Alfresa Holdings Corporation was established in 1984 by Yoshinori Kagawa and began operating in 1986. Yoshinori Kagawa's commitment to innovation, quality, and customer service has led the company through a period of extensive growth and success. Alfresa is a leader in the fields of pharmaceuticals, medical devices, retail pharmacy and dietary supplements.

Mission

Our mission is to improve the lives of people in Japan and around the world by providing high-quality, innovative and affordable healthcare products and services.

Vision

To be the world’s most trusted and respected healthcare company by providing our customers with safe, reliable and cost-effective healthcare products and services.

 

Read More:

negative impact of technology

best free ai business plan generator

ai for business leaders

small artificial intelligence companies

ai business opportunities 2024

Key Team

Mr. Yusuke Fukujin (Deputy Pres & Director)

Shigeki Ohashi (VP, Exe. Officer of Grp Bus, Affiliate Control, Bus Dev & International Bus. and Director)

Soichi Nemoto (Exec. Officer)

Kazuaki Hano (Exec. Officer)

Toshikazu Urakabe (Exec. Officer)

Takashi Sasaki (Exec. Officer)

Miki Oguchi (Exec. Officer)

Recognition and Awards

Alfresa has won numerous awards for excellence in innovation and customer service, including the Minister of Health, Labour and Welfare Quality and Excellence Award in 2005 and the Japan Pharmaceutical Associates International Award in 2006.

References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Alfresa Holdings
Leadership team

Mr. Ryuji Arakawa (Pres & Representative Director)

Toshiki Tanaka (VP, Exec. Officer of Gen Affairs, HR Planning, Digital Transformation (DX) and Compliance & Dir)

Mr. Seiichi Kishida (Deputy Pres, Assistant to the Pres for Fin Planning and Corp. Communication & Director)

Products/ Services
Biotechnology, Health Care, Manufacturing
Number of Employees
1,000 - 20,000
Headquarters
Tokyo, Tokyo, Japan
Established
2003
Company Registration
SEC CIK number: 0000002784
Net Income
100M - 500M
Revenue
Above - 1B
Traded as
TYO:2784